wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33660974-149D9899-8819-48B7-8CF3-4EC0D12C76B6
Q33660974-149D9899-8819-48B7-8CF3-4EC0D12C76B6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33660974-149D9899-8819-48B7-8CF3-4EC0D12C76B6
Synergistic effect of MiR-146a mimic and cetuximab on hepatocellular carcinoma cells.
P2860
Q33660974-149D9899-8819-48B7-8CF3-4EC0D12C76B6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33660974-149D9899-8819-48B7-8CF3-4EC0D12C76B6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a58480f44d2ff7e9063e7524f88157472d8f7e64
P2860
Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma.